Most viewed this week from JAMA Oncology: Prophylactic IV magnesium administration was associated with a lower risk of cisplatin-associated acute kidney injury (CP-AKI) in patients with cancer undergoing cisplatin chemotherapy. ja.ma/44fFHqa

📢 New RCT in kidney transplant patients with chronic active AMR: IVIG (1g/kg x6 months) vs no IVIG (both w/ pulse steroids). 🧬 IVIG stabilized eGFR & improved molecular signatures—despite no DSA change. 💡 Option in pts where escalating immunosuppression is risky. Kidney International

Ten Tips for an Onco-Nephrology Clinic doi.org/10.1093/ckj/sf…

🌍 Great session on ONCO-NEPHROLOGY AND ANTICANCER DRUG TOXICITY 🇮🇹 Held at The 7th International Renal Meeting with Mayo Clinic in Sardinia 📍 Sa Manifattura, Cagliari | May 29–June 1, 2025 | Mayo Clinic Nephrology 🎤 Outstanding talks by: • Dr. Mitchell Rosner (Charlottesville, VA,

A chronicity score based on AI detections showed good prognostic discrimination for kidney failure (cross-validation C-statistic=0.819). Translating this into the clinic work flow with AI derived indices built into pathology reports as shown here will be a game-changer.

Diagnostic Value of #Biological Parameters in #BiopsyConfirmed Thrombotic Microangiopathy #TMA MATRIX Consortium Group #VisualAbstract by Susan Thanabalasingam kireports.org/article/S2468-…

Results of Visionary study using Sibeprenlimab for IgA Nephropathy Vlado Perkovic #ERA25 ERA - European Renal Association

Our review on advances in the treatment of AAV is out now in NatRevRheumatol. It provides an update on currently used therapies and identified major innovations which will become relevant in the next couple of years! EUVAS nature.com/articles/s4158…

In this paper we describe group of patients with MN who had negative IF for PLA2R but had PLA2R detected by LM/MS! Kidney International ⁦Sanjeev Sethi⁩ ⁦Ilario Russo, MD⁩ ⁦fernando fervenza⁩ kidney-international.org/article/S0085-…

The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy fernando fervenza Sanjeev Sethi Ladan Zand #MayoClinicKidney kidney-international.org/article/S0085-…

Combination #Cyclophosphamide and #Rituximab to Minimize #Glucocorticoid Use in Antineutrophil Cytoplasm Antibody–Associated Vasculitis #ANCA #VisualAbstract by Kajaree Giri kireports.org/article/S2468-… Edinburgh Kidney Bean

Can’t wait to see you all in Rochester. Join us Sept 11-12 of 2025. Maria Jose Soler Shruti Gupta Raad Chowdhury, MD, FASN Abhijat Kitchlu | Onconephrology M. Lourdes González Suárez Leticia Rolon Nattawat Klomjit Elena-Bianca Barbir, MD Abdullah Jalal Itunu Priya Alexander, MD BT Workeneh Mayo Clinic Nephrology Aleksandra Kukla

Organ transplantation saves lives. Yet, according to WHO, only 10% of the global need for transplants is being met. In our latest issue, a Comment introduces the ESOTtransplant–Lancet Commission on Transplantation. ➡️ hubs.li/Q03yStP20

I am excited to share our latest paper on the potential association between monoclonal gammopathy and ANCA negative vasculitis. Monoclonal testing should be considered in ANCA negative patients. maria jose vargas fernando fervenza journals.lww.com/kidney360/abst…

Another major milestone for our C3G patients & community!! C3 inhibitor, Pegcetacoplan approved for C3G and IC-MPGN 🧬💊 investors.apellis.com/news-releases/… #C3G #Nephrology #RareDisease #FDAApproval #ComplementTherapy

💡New resources- Management recommendations for kidney transplantation in patients with plasma cell dyscrasia. Useful info on pre-tx eval, post-tx monitoring of recurrence, immunosuppression mgmt. Kidney International Kidney Pancreas Community of Practice - AST w IKMG. More info 👇. kidney-international.org/article/S0085-…

IgM Variant of Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Series bit.ly/3Ec18Od #OpenAccess Bhanu Prasad Sanjeev Sethi #VisualAbstract

Viewpoint discusses how "skimming the median" can exaggerate survival gains in clinical trials, underscoring the need to critically evaluate Kaplan-Meier curves alongside hazard ratios. ja.ma/45mitxx

Don't miss this Mayo Clinic Nephrology conference! Onco-Nephrology Symposium will cover nephrotoxicity of chemotherapeutic agents, patients with dialysis-dependent end-stage renal disease, & much more. Register for Sept. 11-12 in Minnesota & via livestream. ce.mayo.edu/nephrology/con…

Baffling: PGNMID, monoclonal no more I got this consult case as immune complex-MPGN LM- MPGN pattern IF- IgG, C3, C1q, kappa & lambda 3+ Did IgG subtypes-IgG3 3+, all others negative EM- mottled deposits Dx- Proliferative GN, IgG3, but ? with monoclonal IgG deposits (PGNMID)